K
Katie Cullen
Researcher at Research Triangle Park
Publications - 4
Citations - 168
Katie Cullen is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Denosumab & Zoledronic acid. The author has an hindex of 3, co-authored 4 publications receiving 112 citations. Previous affiliations of Katie Cullen include University of North Carolina at Chapel Hill.
Papers
More filters
Journal ArticleDOI
Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Meera Viswanathan,Meera Viswanathan,Shivani Reddy,Shivani Reddy,Nancy D Berkman,Nancy D Berkman,Katie Cullen,Katie Cullen,Jennifer Cook Middleton,Jennifer Cook Middleton,Wanda K. Nicholson,Leila C. Kahwati,Leila C. Kahwati +12 more
TL;DR: In women, screening to prevent osteoporotic fractures may reduce hip fractures, and treatment reduced the risk of vertebral and nonvertebral fractures; there was not consistent evidence of treatment harms.
Book
Screening for Speech and Language Delays and Disorders in Children Age 5 Years or Younger: A Systematic Review for the U.S. Preventive Services Task Force
Nancy D. Berkman,Ina Wallace,Linda R. Watson,Tamera Coyne-Beasley,Katie Cullen,Charles T. Wood,Kathleen N. Lohr +6 more
TL;DR: The evidence on screening and treating children for speech and language delays or disorders for the U.S. Preventive Services Task Force (USPSTF) is evaluated, with a systematic review of evidence for screening and treatment of children age 5 years or younger.
Screening to Prevent Osteoporotic Fractures: An Evidence Review for the U.S. Preventive Services Task Force
Meera Viswanathan,Shivani M. Reddy,Nancy D Berkman,Katie Cullen,Jennifer Cook Middleton,Wanda K. Nicholson,Leila C. Kahwati +6 more
TL;DR: Evidence about screening to prevent osteoporotic fractures for the U.S. Preventive Services Task Force is reviewed, finding available but limited evidence in studies including participants with a wide spectrum of baseline bone mineral density suggests no benefit from repeating a bone measurement test between 4 and 8 years after the initial screen.